New
On March 21, 2024, French health authorities granted special permission for doctors to prescribe Protopic 0.1% (Tacrolimus) for treating vitiligo in adults and children over 2 years old. This kind of permission is given when there's already a different approved treatment available, but this ointment might better meet some patients' needs.
Companies Pierre Fabre Médicament and Léo Pharma A/S that make this ointment must follow certain rules for using it and keeping track of how it's working. This includes regular updates to a health monitoring center in Toulouse and providing summaries of how the treatment is going.
This special permission is set for three years from the day after the decision was announced on the ANSM website. The director general of the health authority, Christelle Ratignier-Carbonneil, signed off on this decision.
FAQOther Questions
- What's the status with official recognition of World Vitiligo Day?
In 2016, the United Nations marked World Vitiligo Day in its International Calendar of Disability Events. However, it was removed in 2019 when the calendar was streamlined to 'M...
- Is it Bitiligo? Vitaligo? Veteligo?
There are so many different ways that people try and spell or even pronounce Vitiligo. Here are some common mis-spellings: bitiligo, vitigo, vitaligo, vitilago, vitiglio, vita...
- Is there a special diet for vitiligo?
Recent research highlights the potential of diet and nutrition in managing vitiligo, offering an alternative where traditional therapies may be lacking. However, the relationshi...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.